Company / EPS (Basic)
PUMA BIOTECHNOLOGY, INC. EPS (Basic) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.46
FY2025
5-year range
-$75595.00 / $0.46
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) has increased for 4 consecutive years, from $-75595.00 in FY2021 to $0.46 in FY2025.
Based on SEC 10-K filings.
0.46 in FY2025.
Improved from $-0.72 to $0.46 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Lowest eps (basic) in the period was in FY2021.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.46 | - |
| FY2024 | $0.00 | +100.0% |
| FY2023 | -$0.72 | +52.6% |
| FY2022 | -$1.52 | +100.0% |
| FY2021 | -$75595.00 | -17580132.6% |
| FY2020 | -$0.43 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026